Phillip P. Chan, Chief Executive Officer at Cytosorbents Corp (CTSO), bought 2,221 shares at $1.85 ($4K) on 2022-06-16, disclosed to the SEC on 2022-06-21.
Scheduled purchase ($4k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTSO | BUY | 2026-06-15 | $105K | — | Filing → |
| CTSO | BUY | 2023-12-15 | $200K | — | Filing → |
| CTSO | BUY | 2022-12-09 | $7K | — | Filing → |